Results 51 to 60 of about 1,330 (141)

Immune persistence and safety of the AS01_E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. [PDF]

Hum Vaccin Immunother
Ferguson M, Schwarz TF, Núñez SA, Rodríguez-García J, Mital M, Zala C, Pek B, Schmitt B, Toursarkissian N, Ochoa Mazarro D, Großkopf J, Voors-Pette C, Mehta H, Amare Hailemariam H, Gérard C, Damaso S, David MP, Descamps D, Hill J, Vandermeulen C, Hulstrøm V.   +20 more
europepmc   +1 more source

Role of the multiple telomeric repeat arrays in integration, persistence, and efficacy of the commercial CVI988 vaccine. [PDF]

mSphere
Bertzbach LD, You Y, Vychodil T, Kheimar A, Kossak L, Sabsabi MA, Conradie AM, Kaufer BB.   +7 more
europepmc   +1 more source

HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition. [PDF]

PLoS Pathog
Myers A, Chandravanshi M, Whitmore LS, Kohrn BF, Negash A, Nguyen DN, Ralli-Jain P, Cruickshank K, Upadhyay AA, Charles T, Edwards CT, Hunter E, Amara RR, Korzeniowski MK, Niu L, Pozharski E, Tolbert WD, Bosinger SE, Kennedy SR, Pazgier M, Derdeyn CA.   +20 more
europepmc   +1 more source

Ferritin Nanocages Exhibit Unique Structural Dynamics When Displaying Surface Protein. [PDF]

Int J Mol Sci
Padariya M, Marek-Trzonkowska N, Kalathiya U.   +2 more
europepmc   +1 more source

An Overview of Avian Vaccination Options in Zoological Collections in Europe. [PDF]

Vet Sci
Leus J, Morel M, Kempf H, Vercammen F, Nederlof RA, Bakker J.   +5 more
europepmc   +1 more source

Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022. [PDF]

Euro Surveill
Canabarro APF, Duffell E, Hansson D, Dudareva S, Seyler T, Niehus R, Ngangro NN, El-Khatib Z, Plettinckx E, Mortgat L, Tyufekchieva M, Theophanous F, Němeček V, Malý M, Wessman M, Aavik HM, Brouard C, Zimmermann R, Paraskevis D, Nikolopoulou G, Molnár Z, Kozma E, Murphy N, Tosti ME, Konova Š, Walser-Domjan E, Hübschen J, Seguin-Devaux C, Melillo T, de Coul EO, Woudenberg T, Whittaker R, Stępień M, Rosińska M, Veríssimo VC, Marinho RT, Hernando V, Diaz A, Axelsson M, Nordahl M, Pericoli F.   +40 more
europepmc   +1 more source

Trained immunity in cancer and autoimmunity: a double-edged sword in immune memory reprogramming. [PDF]

Front Immunol
Salari N, Shams M, Razavi FT, Yazdanpanah E, Oksenych V, Haghmorad D.   +5 more
europepmc   +1 more source

Can Labs Help With Vaccination? In Vitro Tests in Diagnosis of Allergy to COVID-19 Vaccines-A Systematic Review. [PDF]

Immun Inflamm Dis
Romantowski J, Gawinowska M, Trzonkowski P, Niedoszytko M.   +3 more
europepmc   +1 more source

A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens. [PDF]

J Virol
Fan W, Zeng X, Chen Y, Yu Q, Zhang Z, Tian G, Liu C, Bao H, Qi X, Wu L, Zhang Y, Liu Y, Wang S, Cui H, Duan Y, Chen H, Gao Y.   +16 more
europepmc   +1 more source

The use of an avian macrophage-like cell line (HD11) transduced with recombinant lentiviruses to dissect the immunomodulatory role of Marek's disease virus gene products. [PDF]

Virus Genes
Alvarez-Narvaez S, Conrad SJ, Kim T, Spatz S, Dunn JR.   +4 more
europepmc   +1 more source